Skip to content
Search

Latest Stories

New report reveals small rise in NHS dental workforce in England

New report reveals small rise in NHS dental workforce in England

More than 30 million courses of dental treatment were delivered in 2023/24 in England  

A new report published by the NHS Business Services Authority (NHSBSA) reveals that 24,300 dentists performed NHS dental activity in England in 2023/24, marking a 0.4 per cent rise from the previous year’s 24,227.

However, this figure represents a 1.5 per cent decrease from 24,700 dentists with NHS activity in 2019/20.


The report covers NHS dental activity and the NHS dental workforce in England from 2019/20 to 2023/24.

It is the first release from NHSBSA following the transition from NHS England, which previously issued the report.

There were 34 million courses of dental treatment in England for 2023/24, a 4.3 per cent increase from 2022/23. The total units of dental activity (UDAs) rose by 3.4 per cent to 73 million.

Other key findings include:

  • There were 18 million adult patients seen in the 24 months up to the end of March 2024
  • There were 6.7 million child patients seen in the 12 months up to the end of March 2024
  • Courses of treatment for adults increased by 2.2 per cent to 23 million, while those for children rose by 9.0 per cent to 11.2 million.
  • Among child treatment courses, more than 56 per cent included fluoride varnish.

The total number of units of dental activity awarded to dental activity claims was 72.5 million in 2023/24, reflecting a 3.4 per cent increase from the previous year but a 9.1 per cent decrease from the 79.7 million UDAs in 2019/20.

Total revenue from patient charges amounted to £774 million in 2023/24, a 2.7 per cent increase from £754 million the previous year.

In February 2024, the previous government introduced the NHS dental recovery plan, backed by £200 million in funding. The plan was designed to provide over 1.5 million additional NHS dental treatments or up to 2.5 million NHS dental appointments within the next 12 months.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less